Table 3 Percentage of cell protection against H1N1 in combination treatments
From: In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate
Sample | Percentage of protection (mean ± SD) | ||
|---|---|---|---|
Co-pen | Pre-pen | Post-pen | |
Ascorbate + H1N1 | 505.12 ± 2.35 | 287.06 ± 150.79 | 642.65 ± 40.03 |
Acetate + H1N1 | 150.66 ± 3.05 | 145.35 ± 3.95 | 94.52 ± 17.04 |
Citrate + H1N1 | 193.77 ± 77.98 | 135.74 ± 7.25 | 115.40 ± 30.31 |
Amantadine hydrochloride + H1N1 | 57.70 ± 2.73 | 22.08 ± 4.11 | 35.68 ± 27.93 |
Oseltamivir carboxylate + H1N1 | 67.39 ± 0.36 | 62.95 ± 0.70 | 65.63 ± 8.01 |